Shopping Cart
- Remove All
Your shopping cart is currently empty
EGFR/HER2-IN-14 (Compd 46) serves as an inhibitor for drug-resistant mutant EGFR/HER2s. This compound is utilized in cancer research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,270 | 3-6 months | |
| 50 mg | $2,980 | 3-6 months | |
| 100 mg | $4,000 | 3-6 months |
| Description | EGFR/HER2-IN-14 (Compd 46) serves as an inhibitor for drug-resistant mutant EGFR/HER2s. This compound is utilized in cancer research. |
| In vitro | EGFR/HER2-IN-14 exhibits an IC50 of less than 100 nM in Ba/F3 cells transfected with EGFR exon 20 insASV/insSVD and HER2 exon 20 insGSP/insYVMA mutations [1]. |
| Molecular Weight | 575.62 |
| Formula | C32H29N7O4 |
| Cas No. | 3034701-54-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.